Advertisement
UK markets closed
  • FTSE 100

    8,213.49
    +41.34 (+0.51%)
     
  • FTSE 250

    20,164.54
    +112.21 (+0.56%)
     
  • AIM

    771.53
    +3.42 (+0.45%)
     
  • GBP/EUR

    1.1652
    -0.0031 (-0.26%)
     
  • GBP/USD

    1.2546
    +0.0013 (+0.11%)
     
  • Bitcoin GBP

    51,032.16
    +864.20 (+1.72%)
     
  • CMC Crypto 200

    1,327.07
    +50.09 (+3.92%)
     
  • S&P 500

    5,127.79
    +63.59 (+1.26%)
     
  • DOW

    38,675.68
    +450.02 (+1.18%)
     
  • CRUDE OIL

    77.99
    -0.96 (-1.22%)
     
  • GOLD FUTURES

    2,310.10
    +0.50 (+0.02%)
     
  • NIKKEI 225

    38,236.07
    -37.98 (-0.10%)
     
  • HANG SENG

    18,475.92
    +268.79 (+1.48%)
     
  • DAX

    18,001.60
    +105.10 (+0.59%)
     
  • CAC 40

    7,957.57
    +42.92 (+0.54%)
     

New Strong Buy Stocks for April 25th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:

Takeda Pharmaceutical Company Limited TAK: This company that engages in the research, development, manufacture and out-licensing of pharmaceutical products in Japan and globally has seen the Zacks Consensus Estimate for its current year earnings increasing 35.1% over the last 60 days.

Takeda Pharmaceutical Co. Price and Consensus

Takeda Pharmaceutical Co. Price and Consensus
Takeda Pharmaceutical Co. Price and Consensus

Takeda Pharmaceutical Co. price-consensus-chart | Takeda Pharmaceutical Co. Quote

TXO Partners, L.P. TXO: This oil and natural gas company has seen the Zacks Consensus Estimate for its current year earnings increasing 11.3% over the last 60 days.

TXO Partners LP Price and Consensus

TXO Partners LP Price and Consensus
TXO Partners LP Price and Consensus

TXO Partners LP price-consensus-chart | TXO Partners LP Quote

ADVERTISEMENT

PepGen Inc. PEPG: This clinical-stage biotechnology company has seen the Zacks Consensus Estimate for its current year earnings increasing 21.3% over the last 60 days.

PepGen, Inc. Price and Consensus

PepGen, Inc. Price and Consensus
PepGen, Inc. Price and Consensus

PepGen, Inc. price-consensus-chart | PepGen, Inc. Quote

Ero Copper Corp. ERO: This explorer, developer and producer of mining projects in Brazil has seen the Zacks Consensus Estimate for its current year earnings increasing 7.3% over the last 60 days.

Ero Copper Corp. Price and Consensus

Ero Copper Corp. Price and Consensus
Ero Copper Corp. Price and Consensus

Ero Copper Corp. price-consensus-chart | Ero Copper Corp. Quote

Rimini Street, Inc. RMNI: This enterprise software products and services company has seen the Zacks Consensus Estimate for its current year earnings increasing 25.6% over the last 60 days.

Rimini Street, Inc. Price and Consensus

Rimini Street, Inc. Price and Consensus
Rimini Street, Inc. Price and Consensus

Rimini Street, Inc. price-consensus-chart | Rimini Street, Inc. Quote

 

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Ero Copper Corp. (ERO) : Free Stock Analysis Report

Rimini Street, Inc. (RMNI) : Free Stock Analysis Report

Takeda Pharmaceutical Co. (TAK) : Free Stock Analysis Report

PepGen, Inc. (PEPG) : Free Stock Analysis Report

TXO Partners LP (TXO) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research